新加坡 - 英文 - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - dydrogesterone, micronized (in yellow tablet); estradiol hemihydrate 2.06 mg eqv estradiol (micronised) (in brick red tablet); estradiol hemihydrate 2.06 mg eqv estradiol (micronised) (in yellow tablet) - tablet, film coated - 10 mg - dydrogesterone, micronized (in yellow tablet) 10 mg; estradiol hemihydrate 2.06 mg eqv estradiol (micronised) (in brick red tablet) 2 mg; estradiol hemihydrate 2.06 mg eqv estradiol (micronised) (in yellow tablet) 2 mg

比利时 - 英文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

theramex ireland ltd. - estradiol 1 mg (white tablet); estradiol 1 mg (grey tablet); dydrogesterone 10 mg (grey tablet) - tablet - 1 mg - 10 mg - dydrogesterone 10 mg; estradiol 1 mg; estradiol 1 mg - dydrogesterone and estrogen

比利时 - 英文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

theramex ireland ltd. - estradiol hemihydrate 1,03 mg - eq. estradiol 1 mg; dydrogesterone 5 mg - film-coated tablet - 1 mg - 5 mg - dydrogesterone 5 mg; estradiol 1 mg - dydrogesterone and estrogen

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

bgp products ltd - estradiol hemihydrate, dydrogesterone - film coated tablet - 1 mg, 10 m milligram - progestogens and estrogens, sequential preparations

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

bgp products ltd - estradiol, dydrogesterone - film coated tablet - 0.5/2.5 milligram - progestogens and estrogens, fixed combinations

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd - oestradiol; dydrogesterone -

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

viatris limited - estradiol 2mg; dydrogesterone 10mg; estradiol 2mg - tablet - active: estradiol 2mg excipient: colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate maize starch opadry orange oy-23000 active: dydrogesterone 10mg estradiol 2mg excipient: colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate maize starch opadry yellow oy-7915 - hormone replacement therapy (hrt) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uterus. for initiation and continuation of treatment of postmenopausal symptoms, the lowest effective dose for the shortest duration should be used with the goal being short term use.

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

abbott healthcare products ltd - estradiol hemihydrate dydrogesterone - film coated tablet - 1 mg, 10 m milligram

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

bgp products ltd - estradiol hemihydrate, dydrogesterone - film coated tablet - 2 mg, 10 m milligram - progestogens and estrogens, sequential preparations - sequential hormone replacement therapy - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women at least 6 months since the last menses. prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - estradiol, quantity: 1 mg (equivalent: estradiol hemihydrate, qty 1.03 mg); dydrogesterone, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; hypromellose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - hormone replacement therapy (hrt) in oestrogen deficiency associated with natural or artificial menopause in women with an intact uteri. prevention of postmenopausal bone mineral density loss in women. for initiation and continuation of treatment of postmenopausal symptoms, the lowest possible effective dose for the shortest duration should be used with the goal being short term use.